OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A double-edged sword of using opioids and COVID-19: a toxicological view
Mahshid Ataei, Farshad M. Shirazi, Roland J. Lamarine, et al.
Substance Abuse Treatment Prevention and Policy (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Opioid usage and COVID-19 prognosis: A systematic review and meta-analysis
Guangyu Ao, Toni Li, Yushu Wang, et al.
The American Journal of Emergency Medicine (2022) Vol. 56, pp. 51-56
Open Access | Times Cited: 18

Repurposing the drug, ivermectin, in COVID-19: toxicological points of view
Farshad M. Shirazi, Roya Mirzaei, Samaneh Nakhaee, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 17

Investigating the role of opium consumption in the severity, and outcome of COVID-19
Fatemeh Amin, Hamid Ostadebrahimi, Najmeh Parvaz, et al.
Research Square (Research Square) (2025)
Closed Access

From acute SARS-CoV-2 infection to pulmonary hypertension
Emmanuel Eroume À Egom, Haaris A. Shiwani, Brice Nouthe
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 14

COVID‐19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems
Noa Krawczyk, Bianca Rivera, Cale Basaraba, et al.
Addiction (2022) Vol. 118, Iss. 5, pp. 857-869
Open Access | Times Cited: 12

Genetic correlations between COVID-19 and a variety of traits and diseases
Xiao Chang, Yun Li, Kenny Nguyen, et al.
The Innovation (2021) Vol. 2, Iss. 2, pp. 100112-100112
Open Access | Times Cited: 11

The Reasons for Higher Mortality Rate in Opium Addicted Patients with COVID-19: A Narrative Review
Amirhossein Dolati‐Somarin, Bahareh Abd‐Nikfarjam
Iranian Journal of Public Health (2021)
Open Access | Times Cited: 10

Risk of COVID-19 infection and the associated hospitalization, ICU admission and mortality in opioid use disorder: a systematic review and meta-analysis
Amir Hossein Behnoush, Elham Bazmi, Mehdi Forouzesh, et al.
Addiction Science & Clinical Practice (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 7

Maintaining treatment and prevention programs for opioid use disorders during the coronavirus disease 2019 pandemic
Ruihua Li, Min Zhao
Current Opinion in Psychiatry (2021) Vol. 34, Iss. 4, pp. 369-375
Open Access | Times Cited: 9

Opioid-Use, COVID-19 Infection, and Their Neurological Implications
Richa Jalodia, Danielle Antoine, Regina Gonzalez Braniff, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 5

A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment
Fiona Fenton, Siobhán Stokes, Marie Eagleton
Irish Journal of Medical Science (1971 -) (2021) Vol. 191, Iss. 3, pp. 1053-1058
Open Access | Times Cited: 6

Opioids in COVID-19: Two Sides of a Coin
Camila Vantini Capasso Palamim, Matheus Negri Boschiero, Aléthea Guimarães Faria, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 4

Increasing opium use in Iran in response to unsubstantiated rumors that it protects against COVID‐19
Mohsen Khosravi
Addiction (2021) Vol. 117, Iss. 4, pp. 1173-1174
Open Access | Times Cited: 5

The immunomodulatory effects of opioids and implications for intensive care unit populations
Breanne Mefford, John C. Donaldson, Brittany D. Bissell
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2021) Vol. 41, Iss. 8, pp. 668-675
Closed Access | Times Cited: 4

Substances of abuse and their effect on SAR-CoV-2 pathogenesis
Ivy Antwi, Destiny Watkins, Alahn Pedawi, et al.
NeuroImmune Pharmacology and Therapeutics (2023) Vol. 2, Iss. 3, pp. 301-316
Open Access | Times Cited: 1

Genetic correlations between COVID-19 and a variety of traits and diseases
Xiao Chang, Yun Li, Kenny Nguyen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2

Statistical methods for assessing drug interactions using observational data
Qian Xu, Demetra Antimisiaris, Maiying Kong
Journal of Applied Statistics (2022) Vol. 51, Iss. 2, pp. 298-323
Open Access | Times Cited: 1

Opioids and the Immune System
Claudia González‐Espinosa, Iris K. Madera‐Salcedo, Luz M. Molina-Martínez, et al.
Springer eBooks (2022), pp. 249-285
Closed Access | Times Cited: 1

Fájdalomtünetek és a fájdalomcsillapítás lehetőségei SARS-CoV-2-környezetben
Róbert Almási
Orvosi Hetilap (2021) Vol. 162, Iss. 38, pp. 1511-1519
Open Access | Times Cited: 1

Association between opioid abuse and COVID-19 susceptibility: a propensity score matched study
Mojtaba Hedayatyaghoobi, Mehdi Azizmohammad Looha, Arman Shafiee, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access

A Retrospective Cohort Study of SARS-CoV-2 Mortality Rate in Individuals with Opioid Use Disorder in Ilam (Southwest of Iran)
Mohammad Reza Kaffashian, Marzieh Hadavi, Fakhredin Taghinezhad, et al.
Journal of Advances in Medical and Biomedical Research (2022) Vol. 30, Iss. 142, pp. 452-457
Open Access

Substance Use Disorder and COVID-19; Forensic Medicine and Pharmacology Perspectives: A Concise Narrative Review
Ahmed S. Ali, Torki A. Zughaibi, Assmaa Ahmed Shaker
Arab Journal of Forensic Sciences and Forensic Medicine (2021) Vol. 3, Iss. 2, pp. 315-330
Open Access

Page 1

Scroll to top